RE:OkDon't believe its shorters..There are people that have been in this stock for a good while and many had bought at much lower prices, as I have as well. People have also decided to take profits and nothing wrong with that. Now many have noticed this company and its potential, especially at this late stage of their developement and now so so close to that FDA approval which will immediately bring huge Revenues. Its been 3-4 years in the making and even more products were added such as that PharmaPatch and especially the Sairiyo PD-001 product for oncology and infectious diseases...that to me can very problematic as they roll-in the phase 1 clinical trial. Much more to this company today....We have very very low share count...CEO has more that 15.3mm shares to his name and has currently much cash on hand of over $4.5mm and as large blocks of warrants which may be excercised at a share price of .80 cents, raising more that $12mm in additional capital if needed. Market Cap is very low today of $27mm,...Thats way way under valued..and deserves a possible valuation of at least $125mm, in my opinion. Therefore, with only 88mm shares outstanding, stock price may be in the tune of 1.40/share....Everything hinges on that FDA approval which is so close..this stock remains open for further upside in my opinion and have been accumulating as well daily....Good Luck everyone...To each their own...Do your DD and you will come to the same conclusion as a BUY...